Comparison of assessment and management of body fluid exposures between the OHD and A&E
| OHD (%) | A&E (%) | Difference (%) | 95% CI of difference | |
|---|---|---|---|---|
| *As determined by DOH guidelines. | ||||
| Adequacy of risk assessment records | ||||
| Date of incident | 97 (88.99) | 57 (83.82) | 5.17 | −5.37 to 15.71 |
| Time of incident | 84 (77.06) | 49 (72.06) | 5.00 | −8.27 to 18.27 |
| Circumstances of exposure | 89 (81.65) | 33 (48.53) | 33.12 | 19.19 to 47.05 |
| Depth of injury | 78 (71.56) | 28 (41.18) | 30.38 | 15.94 to 44.82 |
| Nature of instrument | 97 (88.99) | 46 (67.65) | 21.34 | 8.76 to 33.92 |
| Needle in artery or vein | 74 (82.22) | 43 (72.88) | 9.34 | −4.48 to 23.16 |
| Source risk assessment recorded | 68 (75.56) | 53 (89.83) | −14.27 | −26.03 to −2.51 |
| Management relating to HBV | ||||
| Enquiry of recipient's HBV immunity | 100 (91.74) | 58 (85.29) | 6.45 | −3.43 to 16.33 |
| Appropriate recipient blood tests* | 109 (99.08) | 59 (86.76) | 12.32 | 3.79 to 20.21 |
| Appropriate HBV PEP* | 97 (88.99) | 45 (66.18) | 22.81 | 10.12 to 35.50 |
| Frequency of source patient testing | ||||
| HBV | 41 (75.93) | 3 (7.5) | 68.43 | 54.41 to 82.45 |
| HCV | 43 (79.63) | 3 (7.5) | 72.13 | 58.64 to 85.62 |
| HIV | 5 (4.17) | 2 (5.51) | −1.34 | p>0.05 (Fisher's exact) |